MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$7,545K
(33.84%↑ Y/Y)
Net loss
-$7,545K
(34.40%↑ Y/Y)
Interest income
$516K
(-73.83%↓ Y/Y)
Loss before income
taxes
-$7,545K
(31.92%↑ Y/Y)
Collaboration revenue
$11,009K
(-12.61%↓ Y/Y)
Total other income,
net
$122K
(-87.63%↓ Y/Y)
Interest expense
$394K
(-60.04%↓ Y/Y)
Total operating
expenses
$18,676K
(-24.29%↓ Y/Y)
Research and development
$12,182K
(-17.71%↓ Y/Y)
General and
administrative
$6,303K
(-36.10%↓ Y/Y)
Restructuring expenses
$191K
Back
Back
Income Statement
source: myfinsight.com
Mersana Therapeutics, Inc. (MRSN)
Mersana Therapeutics, Inc. (MRSN)